Last Updated: September 24, 2026

Details for New Drug Application (NDA): 021306

✉ Email this page to a colleague

NDA 021306 describes BUTRANS, which is a drug marketed by Knoa Pharma and is included in one NDA. It is available from two suppliers. Additional details are available on the BUTRANS profile page.

The generic ingredient in BUTRANS is buprenorphine. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the buprenorphine profile page.

Summary for 021306

Tradename:	BUTRANS
Applicant:	Knoa Pharma
Ingredient:	buprenorphine
Patents:	0

Pharmacology for NDA: 021306

Mechanism of Action	Partial Opioid Agonists

Medical Subject Heading (MeSH) Categories for 021306

Analgesics, Opioid
Narcotic Antagonists
Narcotics

Suppliers and Packaging for NDA: 021306

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
BUTRANS	buprenorphine	FILM, EXTENDED RELEASE;TRANSDERMAL	021306	NDA AUTHORIZED GENERIC	Rhodes Pharmaceuticals LLC	42858-353	42858-353-40	4 POUCH in 1 CARTON (42858-353-40) / 1 PATCH in 1 POUCH / 168 h in 1 PATCH
BUTRANS	buprenorphine	FILM, EXTENDED RELEASE;TRANSDERMAL	021306	NDA AUTHORIZED GENERIC	Rhodes Pharmaceuticals LLC	42858-493	42858-493-40	4 POUCH in 1 CARTON (42858-493-40) / 1 PATCH in 1 POUCH / 168 h in 1 PATCH

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	FILM, EXTENDED RELEASE;TRANSDERMAL			Strength	5MCG/HR
Approval Date:	Jun 30, 2010	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	FILM, EXTENDED RELEASE;TRANSDERMAL			Strength	10MCG/HR
Approval Date:	Jun 30, 2010	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	FILM, EXTENDED RELEASE;TRANSDERMAL			Strength	20MCG/HR
Approval Date:	Jun 30, 2010	TE:	AB	RLD:	Yes

Expired US Patents for NDA 021306

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Knoa Pharma	BUTRANS	buprenorphine	FILM, EXTENDED RELEASE;TRANSDERMAL	021306-003	Jun 30, 2010	5,968,547	⤷ Start Trial
Knoa Pharma	BUTRANS	buprenorphine	FILM, EXTENDED RELEASE;TRANSDERMAL	021306-002	Jun 30, 2010	9,642,850	⤷ Start Trial
Knoa Pharma	BUTRANS	buprenorphine	FILM, EXTENDED RELEASE;TRANSDERMAL	021306-005	Jun 30, 2014	RE41489	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.